Amoy Diagnostics Co., Ltd. (SHE:300685)
22.73
-0.09 (-0.39%)
Jan 14, 2026, 3:04 PM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 8.79 billion as of January 14, 2026. Its market cap has decreased by -8.47% in one year.
Market Cap
8.79B
Enterprise Value
7.58B
Revenue
1.13B
Ranking
n/a
PE Ratio
30.80
Stock Price
22.73
Market Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 8.79B, an increase of 450.68%. That is a compound annual growth rate of 22.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 8.83B | 11.53% |
| Dec 31, 2025 | 7.92B | -11.84% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 423.77B |
| WuXi AppTec | 294.06B |
| Shenzhen Mindray Bio-Medical Electronics | 246.33B |
| Sichuan Biokin Pharmaceutical | 141.99B |
| Shanghai United Imaging Healthcare | 112.68B |
| Aier Eye Hospital Group | 106.16B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.78B |
| Yunnan Baiyao Group Co.,Ltd | 102.27B |